Cleared Traditional

K203723 - Branchor Balloon Guide Catheter

K203723 is the FDA 510(k) clearance for Branchor Balloon Guide Catheter by Asahi Intecc Co., Ltd.. It is a Class 2 Neurology device (product code QJP) cleared through the Traditional 510(k) pathway after a 354-day FDA review.

K203723 · Asahi Intecc Co., Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2021
Decision
354d
Days
Class 2
Risk

K203723 is an FDA 510(k) clearance for the Branchor Balloon Guide Catheter. Classified as Catheter, Percutaneous, Neurovasculature (product code QJP), Class II - Special Controls.

Submitted by Asahi Intecc Co., Ltd. (Seto, JP). The FDA issued a Cleared decision on December 10, 2021 after a review of 354 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1250 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Asahi Intecc Co., Ltd. devices

Submission Details

510(k) Number K203723 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 21, 2020
Decision Date December 10, 2021
Days to Decision 354 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
206d slower than avg
Panel avg: 148d · This submission: 354d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code QJP Catheter, Percutaneous, Neurovasculature
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
Definition To Provide Vascular Access To The Neurovasculature For Interventional Or Diagnostic Procedures
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Asahi Intecc USA, Inc.
Cynthia Valenzuela

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - QJP Catheter, Percutaneous, Neurovasculature

All 90
Devices cleared under the same product code (QJP) and FDA review panel - the closest regulatory comparables to K203723.
Micro Catheter
K202926 · Shanghai Heartcare Medical Technology Co., Ltd. · Feb 2022
EMBOGUARD Balloon Guide Catheter
K212340 · Neuravi Limited · Dec 2021
MIVI Q Distal Access Catheter
K212402 · Mivi Neuroscience, Inc. · Dec 2021
Trevo Trak 21 Microcatheter
K211594 · Stryker Neurovascular · Nov 2021
Spartan MC 0165
K213451 · Spartan Micro · Nov 2021
TracStar LDP Large Distal Platform
K212224 · Imperative Care, Inc. · Sep 2021